The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany: Economic Evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study

Author： Schädlich P.K.   Brecht J.G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.6, 1998-06, pp. : 719-730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Acamprosate and Different Kinds of Psychosocial Support in Relapse Prevention of Alcoholism: Results from a Non-Blind, Multicentre Study

By Soyka M.   Preuss U.   Schuetz C.  

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Relapse Prevention in Alcoholics: A Review of Acamprosate versus Naltrexone

By Hoes M.J.A.J.M.  

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 211-216

Adis International

Access to resources Recommend Favorite

Acamprosate

By Kennedy William Klugh   Leloux Megan   Kutscher Eric C   Price Paul L   Morstad Anne E   Carnahan Ryan M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 363-380

Informa Healthcare

Access to resources Recommend Favorite

Acamprosate

By  

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 13-18

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Schizophrenia Relapse Prevention: An Economic Evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) Study in Spain

By Bernardo Miguel  

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 447-457

Adis International

Access to resources Recommend Favorite